Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 251

1.

De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU.

Timsit JF, Harbarth S, Carlet J.

Intensive Care Med. 2014 Sep 17. [Epub ahead of print] No abstract available.

PMID:
25227655
[PubMed - as supplied by publisher]
2.

Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection.

Harbarth S, von Dach E, Pagani L, Macedo-Vinas M, Huttner B, Olearo F, Emonet S, Uçkay I.

J Antimicrob Chemother. 2014 Sep 10. pii: dku352. [Epub ahead of print]

PMID:
25209610
[PubMed - as supplied by publisher]
3.

Valuation of hospital bed-days released by infection control programs: a comparison of methods.

Stewardson AJ, Harbarth S, Graves N; TIMBER Study Group.

Infect Control Hosp Epidemiol. 2014 Oct;35(10):1294-7. doi: 10.1086/678063. Epub 2014 Sep 3.

PMID:
25203185
[PubMed - in process]
4.

Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence.

Fätkenheuer G, Hirschel B, Harbarth S.

Lancet. 2014 Aug 20. pii: S0140-6736(14)60660-7. doi: 10.1016/S0140-6736(14)60660-7. [Epub ahead of print] No abstract available.

PMID:
25150745
[PubMed - as supplied by publisher]
5.

Mupirocin-Induced Mutations in ileS in Various Genetic Backgrounds of Methicillin-Resistant Staphylococcus aureus.

Lee AS, Gizard Y, Empel J, Bonetti EJ, Harbarth S, François P.

J Clin Microbiol. 2014 Oct;52(10):3749-54. doi: 10.1128/JCM.01010-14. Epub 2014 Aug 13.

PMID:
25122856
[PubMed - in process]
6.

Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus.

Kock R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Witte W, Friedrich AW.

Euro Surveill. 2014 Jul 24;19(29). pii: 20860.

PMID:
25080142
[PubMed - in process]
Free Article
7.

Thirteen years of surgical site infection surveillance in Swiss hospitals.

Staszewicz W, Eisenring MC, Bettschart V, Harbarth S, Troillet N.

J Hosp Infect. 2014 Sep;88(1):40-7. doi: 10.1016/j.jhin.2014.06.003. Epub 2014 Jul 4.

PMID:
25063012
[PubMed - in process]
8.

Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies.

Bettiol E, Rottier WC, Del Toro MD, Harbarth S, Bonten MJ, Rodríguez-Baño J; COMBACTE consortium.

Future Microbiol. 2014 Jun;9(6):757-71. doi: 10.2217/fmb.14.35.

PMID:
25046523
[PubMed - in process]
9.

The impact of infectious disease specialists on antibiotic prescribing in hospitals.

Pulcini C, Botelho-Nevers E, Dyar OJ, Harbarth S.

Clin Microbiol Infect. 2014 Jul 4. doi: 10.1111/1469-0691.12751. [Epub ahead of print]

PMID:
25039787
[PubMed - as supplied by publisher]
10.

Infection control measures to decrease the burden of antimicrobial resistance in the critical care setting.

Landelle C, Marimuthu K, Harbarth S.

Curr Opin Crit Care. 2014 Oct;20(5):499-506. doi: 10.1097/MCC.0000000000000126.

PMID:
25032821
[PubMed - in process]
11.

Screening for methicillin-resistant Staphylococcus aureus … all doors closed?

Marimuthu K, Harbarth S.

Curr Opin Infect Dis. 2014 Aug;27(4):356-62. doi: 10.1097/QCO.0000000000000081.

PMID:
25029612
[PubMed - in process]
12.

Is reduced susceptibility to disinfectants and antiseptics a risk in healthcare settings? A point/counterpoint review.

Harbarth S, Tuan Soh S, Horner C, Wilcox MH.

J Hosp Infect. 2014 Aug;87(4):194-202. doi: 10.1016/j.jhin.2014.04.012. Epub 2014 Jun 5.

PMID:
24996517
[PubMed - in process]
13.

Complete Genome Sequences of Nitrofurantoin-Sensitive and -Resistant Escherichia coli ST540 and ST2747 Strains.

Xavier BB, Vervoort J, Stewardson A, Adriaenssens N, Coenen S, Harbarth S, Goossens H, Malhotra-Kumar S.

Genome Announc. 2014 Apr 10;2(2). pii: e00239-14. doi: 10.1128/genomeA.00239-14.

PMID:
24723707
[PubMed]
Free PMC Article
14.

Multilevel competing risk models to evaluate the risk of nosocomial infection.

Wolkewitz M, Cooper BS, Palomar-Martinez M, Alvarez-Lerma F, Olaechea-Astigarraga P, Barnett AG, Harbarth S, Schumacher M.

Crit Care. 2014 Apr 8;18(2):R64. doi: 10.1186/cc13821.

PMID:
24713511
[PubMed - in process]
Free PMC Article
15.

Does colonization with methicillin-susceptible Staphylococcus aureus protect against nosocomial acquisition of methicillin-resistant S. aureus?

Landelle C, Iten A, Uçkay I, Sax H, Camus V, Cohen G, Renzi G, Schrenzel J, Pittet D, Perrier A, Harbarth S.

Infect Control Hosp Epidemiol. 2014 May;35(5):527-33. doi: 10.1086/675825. Epub 2014 Mar 19.

PMID:
24709721
[PubMed - in process]
16.

Infection control interventions in small rural hospitals with limited resources: results of a cluster-randomized feasibility trial.

Stevenson KB, Searle K, Curry G, Boyce JM, Harbarth S, Stoddard GJ, Samore MH.

Antimicrob Resist Infect Control. 2014 Mar 28;3(1):10. doi: 10.1186/2047-2994-3-10.

PMID:
24678604
[PubMed]
Free PMC Article
17.

Extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital food: a risk assessment.

Stewardson AJ, Renzi G, Maury N, Vaudaux C, Brossier C, Fritsch E, Pittet D, Heck M, van der Zwaluw K, Reuland EA, van de Laar T, Snelders E, Vandenbroucke-Grauls C, Kluytmans J, Edder P, Schrenzel J, Harbarth S.

Infect Control Hosp Epidemiol. 2014 Apr;35(4):375-83. doi: 10.1086/675609.

PMID:
24602942
[PubMed - in process]
18.

Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study.

Bloos F, Thomas-Rüddel D, Rüddel H, Engel C, Schwarzkopf D, Marshall JC, Harbarth S, Simon P, Riessen R, Keh D, Dey K, Weiß M, Toussaint S, Schädler D, Weyland A, Ragaller M, Schwarzkopf K, Eiche J, Kuhnle G, Hoyer H, Hartog C, Kaisers U, Reinhart K; MEDUSA Study Group.

Crit Care. 2014 Mar 3;18(2):R42. doi: 10.1186/cc13755.

PMID:
24589043
[PubMed - in process]
Free PMC Article
19.

An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.

Wong G, Brinkman A, Benefield RJ, Carlier M, De Waele JJ, El Helali N, Frey O, Harbarth S, Huttner A, McWhinney B, Misset B, Pea F, Preisenberger J, Roberts MS, Robertson TA, Roehr A, Sime FB, Taccone FS, Ungerer JP, Lipman J, Roberts JA.

J Antimicrob Chemother. 2014 May;69(5):1416-23. doi: 10.1093/jac/dkt523. Epub 2014 Jan 16.

PMID:
24443514
[PubMed - in process]
20.

[Clostridium difficile infections, specific issues in the elderly].

Castrillon BO, Harbarth S, Prendki V.

Rev Med Suisse. 2013 Nov 6;9(405):2044-8. French.

PMID:
24308141
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk